%0 Journal Article
%T 胶质母细胞瘤的最新治疗进展<br>Recent Advances in the Treatment of Glioblastoma
%A 艾山·艾麦尔
%A 亚森·奥斯曼
%A 穆妮日·图尔贡
%A 刘波
%J Advances in Clinical Medicine
%P 6681-6685
%@ 2161-8720
%D 2023
%I Hans Publishing
%R 10.12677/ACM.2023.134934
%X 胶质母细胞瘤是中枢神经系统中最常见和高度恶性的原发性肿瘤。经过多年的研究，胶质母细胞瘤的治疗取得了各种治疗的进展。目前，胶质母细胞瘤的治疗是基于最大限度的安全手术切除，放射治疗和替莫唑胺的化疗。最近，贝伐单抗及肿瘤治疗电场已被加入到治疗。然而，胶质母细胞瘤患者仍然预后不佳。因此，在不同的临床研究领域正在做出许多努力寻找一种新的替代方法来改善胶质母细胞瘤患者的总生存率、无进展生存率和生活质量。<br />
Glioblastoma is the most common and highly malignant primary neoplasm in the central nervous system. After many years of research, the treatment of glioblastoma has made progress in various treatments. Currently, the treatment of glioblastoma is based on maximal safe surgical resection, radiotherapy, and chemotherapy with temozolomide. Recently, bevacizumab and tumor treatment electric fields have been added to the treatment. However, patients with glioblastoma still have a poor prognosis. Therefore, many efforts are being made in different clinical research areas to find a new alternative approach to improve overall survival, progression-free survival and quality of life in patients with glioblastoma.
%K 胶质母细胞瘤，治疗进展，综述<br>Glioblastoma
%K Therapeutic Advances
%K Review
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=64635